Abbott Laboratories (ABT): Price and Financial Metrics

Abbott Laboratories (ABT): $119.46

0.44 (+0.37%)

POWR Rating

Component Grades








ABT Price/Volume Stats

Current price $119.46 52-week high $120.15
Prev. close $119.02 52-week low $89.67
Day low $118.86 Volume 4,261,500
Day high $120.15 Avg. volume 5,491,430
50-day MA $112.10 Dividend yield 1.87%
200-day MA $105.12 Market Cap 207.29B

ABT Stock Price Chart Interactive Chart >


  • Stability is the dimension where ABT ranks best; there it ranks ahead of 89.62% of US stocks.
  • The strongest trend for ABT is in Growth, which has been heading up over the past 26 weeks.
  • ABT's current lowest rank is in the Momentum metric (where it is better than 24.39% of US stocks).

ABT Stock Summary

  • ABBOTT LABORATORIES's market capitalization of $190,133,130,863 is ahead of 98.98% of US-listed equities.
  • ABBOTT LABORATORIES's stock had its IPO on January 1, 1986, making it an older stock than 92.92% of US equities in our set.
  • In terms of volatility of its share price, ABT is more volatile than merely 7.32% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to ABBOTT LABORATORIES, a group of peers worth examining would be DHR, TMO, SHEL, CAT, and GE.
  • ABT's SEC filings can be seen here. And to visit ABBOTT LABORATORIES's official web site, go to

ABT Valuation Summary

  • In comparison to the median Healthcare stock, ABT's price/sales ratio is 14.29% higher, now standing at 4.8.
  • ABT's price/sales ratio has moved up 0.9 over the prior 243 months.

Below are key valuation metrics over time for ABT.

Stock Date P/S P/B P/E EV/EBIT
ABT 2023-12-29 4.8 5.1 37.0 29.3
ABT 2023-12-28 4.8 5.1 37.1 29.4
ABT 2023-12-27 4.8 5.1 36.9 29.2
ABT 2023-12-26 4.7 5.0 36.7 29.1
ABT 2023-12-22 4.7 5.0 36.7 29.0
ABT 2023-12-21 4.7 5.0 36.5 28.9

ABT Growth Metrics

    The 5 year net cashflow from operations growth rate now stands at 91.66%.
  • The 2 year cash and equivalents growth rate now stands at 127.27%.
  • Its 4 year revenue growth rate is now at 53.91%.
Over the past 15 months, ABT's revenue has gone up $4,797,000,000.

The table below shows ABT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 45,030 10,322 7,889
2022-06-30 45,548 10,243 8,554
2022-03-31 44,514 9,961 7,725
2021-12-31 43,075 10,533 7,071
2021-09-30 42,308 11,264 7,244
2021-06-30 40,233 10,629 6,376

ABT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ABT has a Quality Grade of B, ranking ahead of 77.76% of graded US stocks.
  • ABT's asset turnover comes in at 0.559 -- ranking 70th of 680 Pharmaceutical Products stocks.
  • DVAX, RARE, and CORT are the stocks whose asset turnover ratios are most correlated with ABT.

The table below shows ABT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.559 0.557 0.230
2021-03-31 0.527 0.568 0.205
2020-12-31 0.499 0.566 0.166
2020-09-30 0.473 0.567 0.135
2020-06-30 0.462 0.576 0.128
2020-03-31 0.473 0.584 0.147

ABT Price Target

For more insight on analysts targets of ABT, see our ABT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $132.05 Average Broker Recommendation 1.48 (Moderate Buy)

Abbott Laboratories (ABT) Company Bio

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013. (Source:Wikipedia)

ABT Latest News Stream

Event/Time News Detail
Loading, please wait...

ABT Latest Social Stream

Loading social stream, please wait...

View Full ABT Social Stream

Latest ABT News From Around the Web

Below are the latest news stories about ABBOTT LABORATORIES that investors may wish to consider to help them evaluate ABT as an investment opportunity.

Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet

According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Yahoo | December 28, 2023

Silver Economy Successes: 3 Stocks Benefitting From an Aging Population

Explore our in-depth analysis of aging population stocks, uncovering the opportunities and challenges in this sector.

Faizan Farooque on InvestorPlace | December 27, 2023

Abbott (ABT) Laps the Stock Market: Here's Why

In the closing of the recent trading day, Abbott (ABT) stood at $109.79, denoting a +0.51% change from the preceding trading day.

Yahoo | December 27, 2023

Watch These 5 Stocks That Recently Hiked Dividends

Investors may keep a tab on stocks like FULT, SFBS, MOS, ABT and ANDE, which have lately hiked their dividend payments.

Yahoo | December 27, 2023

5 Top Stocks to Buy With Your End-of-the-Year Bonus

Your bonus could become the gift that keeps on giving.

Yahoo | December 23, 2023

Read More 'ABT' Stories Here

ABT Price Returns

1-mo 6.65%
3-mo 16.87%
6-mo 16.20%
1-year 21.33%
3-year 3.56%
5-year 69.30%
YTD 9.06%
2023 2.26%
2022 -20.68%
2021 30.53%
2020 28.04%
2019 22.08%

ABT Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ABT Dividend History

Continue Researching ABT

Here are a few links from around the web to help you further your research on Abbott Laboratories's stock as an investment opportunity:

Abbott Laboratories (ABT) Stock Price | Nasdaq
Abbott Laboratories (ABT) Stock Quote, History and News - Yahoo Finance
Abbott Laboratories (ABT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!